Filter announcements
Loading...
Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products.
Business Update First Phase of Manufacturing Capacity Expansion Completed Ahead of Schedule
Newspaper publication for completion of dispatch of the notice of 41st AGM and Annual report for the FY 2025-26
Morepen Laboratories' Board has proposed a final dividend of ₹ 0.20 per equity share for the financial year, subject to shareholder approval at the upcoming AGM. The dividend record date is September 19.
Morepen Laboratories Limited has informed the Exchange about Shareholders meeting
Newspaper publication-information relating to 41st Annual General Meeting, Dividend and Record Date